Revolax Fine Lidocaine is an injectable gel designed for facial contouring, specifically for the correction of fine lines and wrinkles, as well as improving skin texture. The product is a dermal filler based on hyaluronic acid, with the addition of a local anesthetic, lidocaine, to reduce pain during the injection. Revolax Fine Lidocaine is ideal for restoring skin volume, improving its texture, and achieving a natural, harmonious result.
Manufacturer: Revolax, a well-known South Korean company specializing in the development and production of high-quality dermal fillers that meet strict international standards for safety and effectiveness.
Composition. Methods and Techniques of Application.
Composition:
Hyaluronic Acid – 24 mg/ml. The main active ingredient that provides moisture, firmness, and elasticity to the skin.
Lidocaine – 0.3%, for anesthetic effect and patient comfort during the procedure.
Methods and Techniques of Application:
Revolax Fine Lidocaine is used for injections into the upper layers of the dermis. It is the ideal choice for correcting fine facial wrinkles, such as crow’s feet, nasolabial folds, and for restoring skin tone and texture.
The procedure is performed by a qualified specialist in a clinical setting. The product is injected using an ultra-fine needle or cannula, minimizing tissue trauma and reducing the likelihood of bruising. After the injections, the patient can immediately resume normal activities, with minimal restrictions during the first 24 hours.
Applications:
Local injections to reduce wrinkles and lines.
Subtle correction of facial contours and improvement of skin texture.
Procedures aimed at restoring volume in the cheeks, nasolabial folds, and under-eye areas.
Contraindications.
Contraindications:
Hypersensitivity to any of the components of the product (hyaluronic acid or lidocaine).
Pregnancy and breastfeeding.
Acute inflammatory skin conditions at the injection site.
Active autoimmune diseases.
Blood clotting disorders or conditions requiring anticoagulant therapy.
A history of oncological diseases.
Infectious diseases at the planned injection site.
Before undergoing the procedure, it is essential to consult with a physician who will assess potential risks and provide recommendations based on the patient’s health condition.
This description is for informational purposes only.
We use cookies to ensure the proper functioning of our website, to personalize advertisements and other materials, to enable social media features, and to analyze network traffic. We also provide information about how you use our site, our social media partners, advertising and analytics.
